← Eichor
Condition: Severe Dry Eye Syndromes Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Dry Eye Syndromes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune D
Phase 4 · 1 location(s) · Toyos Clinic · NCT06964269Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops.
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT07632534The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06830551A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
Phase 3 · 1 location(s) · Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · NCT06766357MTS109 in Patients With Refractory Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Shanghai Changzheng Hospital · NCT07526350A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Phase 1 · 11 location(s) · Cullinan Therapeutics Inc. · NCT07041099Detection and Optimization of Treatment of Severe Cases of Dry Eye Disease
Phase N/A · 1 location(s) · Singapore National Eye Centre · NCT075549113% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
Phase 3 · 1 location(s) · The University of Hong Kong · NCT06903884Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT03358979Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hy
NA · 2 location(s) · FB Vision S.p.A · NCT07412860Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06831253Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye
Phase 2 · 1 location(s) · University of Miami · NCT07413172A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Managemen
NA · 5 location(s) · Dr. Gerhard Mann chem.-pharm. Fabrik GmbH · NCT07593885
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.